Angelique Mittan, CLS

Angelique Mittan, CLS has over 28 years of experience in the pharmaceutical industry. Angelique currently serves as the Senior Director of Clinical Operations at 4D Molecular Therapeutics, where they provide leadership and management for ophthalmology clinical trials. In this role, they also manage service providers and provides strategic oversight for the company's portfolio.

Prior to their current position, Mittan worked as the Director of Clinical Operations and Patient Advocacy at Chinook Therapeutics, Inc. from 2019 to 2021. Here, they managed the renal program and led the patient advocacy efforts for the company.

From 2018 to 2019, Mittan served as the Director of Clinical Operations at Astex Pharmaceuticals (US), where they were responsible for managing clinical operations staff and the oncology program.

Mittan also has extensive experience at Genentech, where they held various roles including Senior Functional Manager, Senior Clinical Program Manager, and Senior Clinical Study Manager. In these positions, they provided leadership and management for global oncology clinical studies and cross-functional projects.

Earlier in their career, Mittan worked at Astex Pharmaceuticals (US), Gilead Sciences, Covidien, and UCSF Medical Center, where they gained experience in managing clinical trials and operational aspects of various therapeutic areas.

Overall, Angelique Mittan's work experience demonstrates their expertise in clinical operations, patient advocacy, and leadership in the pharmaceutical industry.

Angelique Mittan, CLS holds a Bachelor of Arts (BA) degree in Cellular Biology and Physiology from the University of California, Berkeley.